welcome
Insider

Insider

Health

Health

Pfizer's CEO says he's got a plan to deal with Trump's tariffs — move overseas drug manufacturing to the US

Insider
Summary
Nutrition label

76% Informative

Pfizer CEO Albert Bourla said the company may move overseas drug manufacturing back to the US if President Donald Trump 's tariffs affect it.

Bourla was speaking at TD Cowen's annual healthcare conference on Monday .

He said Pfizer has 13 manufacturing sites in the US and some facilities are "mega, mega sites".